TABLE OF CONTENTS 1 Research Methodology and Statistical Scope 1.1 Market Definition and Statistical Scope of Antidiabetics 1.2 Key Market Segments 1.2.1 Antidiabetics Segment by Type 1.2.2 Antidiabetics Segment by Application 1.3 Methodology & Sources of Information 1.3.1 Research Methodology 1.3.2 Research Process 1.3.3 Market Breakdown and Data Triangulation 1.3.4 Base Year 1.3.5 Report Assumptions & Caveats 2 Antidiabetics Market Overview 2.1 Global Market Overview 2.1.1 Global Antidiabetics Market Size (M USD) Estimates and Forecasts (2017-2028) 2.1.2 Global Antidiabetics Sales Estimates and Forecasts (2017-2028) 2.2 Market Segment Executive Summary 2.3 Global Market Size by Region 3 Antidiabetics Market Competitive Landscape 3.1 Global Antidiabetics Sales by Manufacturers (2017-2022) 3.2 Global Antidiabetics Revenue Market Share by Manufacturers (2017-2022) 3.3 Antidiabetics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4 Global Antidiabetics Average Price by Manufacturers (2017-2022) 3.5 Manufacturers Antidiabetics Sales Sites, Area Served, Product Type 3.6 Antidiabetics Market Competitive Situation and Trends 3.6.1 Antidiabetics Market Concentration Rate 3.6.2 Global 5 and 10 Largest Antidiabetics Players Market Share by Revenue 3.6.3 Mergers & Acquisitions, Expansion 4 Antidiabetics Industry Chain Analysis 4.1 Antidiabetics Industry Chain Analysis 4.2 Market Overview and Market Concentration Analysis of Key Raw Materials 4.3 Midstream Market Analysis 4.4 Downstream Customer Analysis 5 The Development and Dynamics of Antidiabetics Market 5.1 Key Development Trends 5.2 Driving Factors 5.3 Market Challenges 5.4 Market Restraints 5.5 Industry News 5.5.1 New Product Developments 5.5.2 Mergers & Acquisitions 5.5.3 Expansions 5.5.4 Collaboration/Supply Contracts 5.6 Industry Policies 6 Antidiabetics Market Segmentation by Type 6.1 Evaluation Matrix of Segment Market Development Potential (Type) 6.2 Global Antidiabetics Sales Market Share by Type (2017-2022) 6.3 Global Antidiabetics Market Size Market Share by Type (2017-2022) 6.4 Global Antidiabetics Price by Type (2017-2022) 7 Antidiabetics Market Segmentation by Application 7.1 Evaluation Matrix of Segment Market Development Potential (Application) 7.2 Global Antidiabetics Market Sales by Application (2017-2022) 7.3 Global Antidiabetics Market Size (M USD) by Application (2017-2022) 7.4 Global Antidiabetics Sales Growth Rate by Application (2017-2022) 8 Antidiabetics Market Segmentation by Region 8.1 Global Antidiabetics Sales by Region 8.1.1 Global Antidiabetics Sales by Region 8.1.2 Global Antidiabetics Sales Market Share by Region 8.2 North America 8.2.1 North America Antidiabetics Sales by Country 8.2.2 U.S. 8.2.3 Canada 8.2.4 Mexico 8.3 Europe 8.3.1 Europe Antidiabetics Sales by Country 8.3.2 Germany 8.3.3 France 8.3.4 U.K. 8.3.5 Italy 8.3.6 Russia 8.4 Asia Pacific 8.4.1 Asia Pacific Antidiabetics Sales by Region 8.4.2 China 8.4.3 Japan 8.4.4 South Korea 8.4.5 India 8.4.6 Southeast Asia 8.5 South America 8.5.1 South America Antidiabetics Sales by Country 8.5.2 Brazil 8.5.3 Argentina 8.5.4 Columbia 8.6 Middle East and Africa 8.6.1 Middle East and Africa Antidiabetics Sales by Region 8.6.2 Saudi Arabia 8.6.3 UAE 8.6.4 Egypt 8.6.5 Nigeria 8.6.6 South Africa 9 Key Companies Profiled 9.1 Sanofi-Aventis 9.1.1 Sanofi-Aventis Antidiabetics Basic Information 9.1.2 Sanofi-Aventis Antidiabetics Product Overview 9.1.3 Sanofi-Aventis Antidiabetics Product Market Performance 9.1.4 Sanofi-Aventis Business Overview 9.1.5 Sanofi-Aventis Antidiabetics SWOT Analysis 9.1.6 Sanofi-Aventis Recent Developments 9.2 Takeda Pharmaceuticals 9.2.1 Takeda Pharmaceuticals Antidiabetics Basic Information 9.2.2 Takeda Pharmaceuticals Antidiabetics Product Overview 9.2.3 Takeda Pharmaceuticals Antidiabetics Product Market Performance 9.2.4 Takeda Pharmaceuticals Business Overview 9.2.5 Takeda Pharmaceuticals Antidiabetics SWOT Analysis 9.2.6 Takeda Pharmaceuticals Recent Developments 9.3 Eli Lilly 9.3.1 Eli Lilly Antidiabetics Basic Information 9.3.2 Eli Lilly Antidiabetics Product Overview 9.3.3 Eli Lilly Antidiabetics Product Market Performance 9.3.4 Eli Lilly Business Overview 9.3.5 Eli Lilly Antidiabetics SWOT Analysis 9.3.6 Eli Lilly Recent Developments 9.4 Oramed Pharmaceuticals 9.4.1 Oramed Pharmaceuticals Antidiabetics Basic Information 9.4.2 Oramed Pharmaceuticals Antidiabetics Product Overview 9.4.3 Oramed Pharmaceuticals Antidiabetics Product Market Performance 9.4.4 Oramed Pharmaceuticals Business Overview 9.4.5 Oramed Pharmaceuticals Antidiabetics SWOT Analysis 9.4.6 Oramed Pharmaceuticals Recent Developments 9.5 Boehringer Ingelheim 9.5.1 Boehringer Ingelheim Antidiabetics Basic Information 9.5.2 Boehringer Ingelheim Antidiabetics Product Overview 9.5.3 Boehringer Ingelheim Antidiabetics Product Market Performance 9.5.4 Boehringer Ingelheim Business Overview 9.5.5 Boehringer Ingelheim Antidiabetics SWOT Analysis 9.5.6 Boehringer Ingelheim Recent Developments 9.6 Merck and Co. Inc. 9.6.1 Merck and Co. Inc. Antidiabetics Basic Information 9.6.2 Merck and Co. Inc. Antidiabetics Product Overview 9.6.3 Merck and Co. Inc. Antidiabetics Product Market Performance 9.6.4 Merck and Co. Inc. Business Overview 9.6.5 Merck and Co. Inc. Recent Developments 9.7 Novo Nordisk 9.7.1 Novo Nordisk Antidiabetics Basic Information 9.7.2 Novo Nordisk Antidiabetics Product Overview 9.7.3 Novo Nordisk Antidiabetics Product Market Performance 9.7.4 Novo Nordisk Business Overview 9.7.5 Novo Nordisk Recent Developments 9.8 Bristol-Myers Squibb 9.8.1 Bristol-Myers Squibb Antidiabetics Basic Information 9.8.2 Bristol-Myers Squibb Antidiabetics Product Overview 9.8.3 Bristol-Myers Squibb Antidiabetics Product Market Performance 9.8.4 Bristol-Myers Squibb Business Overview 9.8.5 Bristol-Myers Squibb Recent Developments 9.9 Halozyme Therapeutics 9.9.1 Halozyme Therapeutics Antidiabetics Basic Information 9.9.2 Halozyme Therapeutics Antidiabetics Product Overview 9.9.3 Halozyme Therapeutics Antidiabetics Product Market Performance 9.9.4 Halozyme Therapeutics Business Overview 9.9.5 Halozyme Therapeutics Recent Developments 9.10 Pfizer 9.10.1 Pfizer Antidiabetics Basic Information 9.10.2 Pfizer Antidiabetics Product Overview 9.10.3 Pfizer Antidiabetics Product Market Performance 9.10.4 Pfizer Business Overview 9.10.5 Pfizer Recent Developments 10 Antidiabetics Market Forecast by Region 10.1 Global Antidiabetics Market Size Forecast 10.2 Global Antidiabetics Market Forecast by Region 10.2.1 North America Market Size Forecast by Country 10.2.2 Europe Antidiabetics Market Size Forecast by Country 10.2.3 Asia Pacific Antidiabetics Market Size Forecast by Region 10.2.4 South America Antidiabetics Market Size Forecast by Country 10.2.5 Middle East and Africa Forecasted Consumption of Antidiabetics by Country 11 Forecast Market by Type and by Application (2022-2028) 11.1 Global Antidiabetics Market Forecast by Type (2022-2028) 11.1.1 Global Forecasted Sales of Antidiabetics by Type (2022-2028) 11.1.2 Global Antidiabetics Market Size Forecast by Type (2022-2028) 11.1.3 Global Forecasted Price of Antidiabetics by Type (2022-2028) 11.2 Global Antidiabetics Market Forecast by Application (2022-2028) 11.2.1 Global Antidiabetics Sales (K Units) Forecast by Application 11.2.2 Global Antidiabetics Market Size (M USD) Forecast by Application (2022-2028) 12 Conclusion and Key Findings

LIST OF TABLES Table 1. Introduction of the Type Table 2. Introduction of the Application Table 3. Market Size (M USD) Segment Executive Summary Table 4. Antidiabetics Market Size (M USD) Comparison by Region (M USD) Table 5. Global Antidiabetics Sales (K Units) by Manufacturers (2017-2022) Table 6. Global Antidiabetics Sales Market Share by Manufacturers (2017-2022) Table 7. Global Antidiabetics Revenue (M USD) by Manufacturers (2017-2022) Table 8. Global Antidiabetics Revenue Share by Manufacturers (2017-2022) Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antidiabetics as of 2021) Table 10. Global Market Antidiabetics Average Price (USD/Unit) of Key Manufacturers (2017-2022) Table 11. Manufacturers Antidiabetics Sales Sites and Area Served Table 12. Manufacturers Antidiabetics Product Type Table 13. Global Antidiabetics Manufacturers Market Concentration Ratio (CR5 and HHI) Table 14. Mergers & Acquisitions, Expansion Plans Table 15. Industry Chain Map of Antidiabetics Table 16. Raw Materials Table 17. Midstream Market Analysis Table 18. Downstream Customer Analysis Table 19. Key Development Trends Table 20. Driving Factors Table 21. Antidiabetics Market Challenges Table 22. Market Restraints Table 23. Global Antidiabetics Sales by Type (K Units) Table 24. Global Antidiabetics Market Size by Type (M USD) Table 25. Global Antidiabetics Sales (K Units) by Type (2017-2022) Table 26. Global Antidiabetics Sales Market Share by Type (2017-2022) Table 27. Global Antidiabetics Market Size (M USD) by Type (2017-2022) Table 28. Global Antidiabetics Market Size Share by Type (2017-2022) Table 29. Global Antidiabetics Price (USD/Unit) by Type (2017-2022) Table 30. Global Antidiabetics Sales (K Units) by Application Table 31. Global Antidiabetics Market Size by Application Table 32. Global Antidiabetics Sales by Application (2017-2022) & (K Units) Table 33. Global Antidiabetics Sales Market Share by Application (2017-2022) Table 34. Global Antidiabetics Sales by Application (2017-2022) & (M USD) Table 35. Global Antidiabetics Market Share by Application (2017-2022) Table 36. Global Antidiabetics Sales Growth Rate by Application (2017-2022) Table 37. Global Antidiabetics Sales by Region (2017-2022) & (K Units) Table 38. Global Antidiabetics Sales Market Share by Region (2017-2022) Table 39. North America Antidiabetics Sales by Country (2017-2022) & (K Units) Table 40. Europe Antidiabetics Sales by Country (2017-2022) & (K Units) Table 41. Asia Pacific Antidiabetics Sales by Region (2017-2022) & (K Units) Table 42. South America Antidiabetics Sales by Country (2017-2022) & (K Units) Table 43. Middle East and Africa Antidiabetics Sales by Region (2017-2022) & (K Units) Table 44. Sanofi-Aventis Antidiabetics Basic Information Table 45. Sanofi-Aventis Antidiabetics Product Overview Table 46. Sanofi-Aventis Antidiabetics Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 47. Sanofi-Aventis Business Overview Table 48. Sanofi-Aventis Antidiabetics SWOT Analysis Table 49. Sanofi-Aventis Recent Developments Table 50. Takeda Pharmaceuticals Antidiabetics Basic Information Table 51. Takeda Pharmaceuticals Antidiabetics Product Overview Table 52. Takeda Pharmaceuticals Antidiabetics Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 53. Takeda Pharmaceuticals Business Overview Table 54. Takeda Pharmaceuticals Antidiabetics SWOT Analysis Table 55. Takeda Pharmaceuticals Recent Developments Table 56. Eli Lilly Antidiabetics Basic Information Table 57. Eli Lilly Antidiabetics Product Overview Table 58. Eli Lilly Antidiabetics Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 59. Eli Lilly Business Overview Table 60. Eli Lilly Antidiabetics SWOT Analysis Table 61. Eli Lilly Recent Developments Table 62. Oramed Pharmaceuticals Antidiabetics Basic Information Table 63. Oramed Pharmaceuticals Antidiabetics Product Overview Table 64. Oramed Pharmaceuticals Antidiabetics Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 65. Oramed Pharmaceuticals Business Overview Table 66. Oramed Pharmaceuticals Antidiabetics SWOT Analysis Table 67. Oramed Pharmaceuticals Recent Developments Table 68. Boehringer Ingelheim Antidiabetics Basic Information Table 69. Boehringer Ingelheim Antidiabetics Product Overview Table 70. Boehringer Ingelheim Antidiabetics Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 71. Boehringer Ingelheim Business Overview Table 72. Boehringer Ingelheim Antidiabetics SWOT Analysis Table 73. Boehringer Ingelheim Recent Developments Table 74. Merck and Co. Inc. Antidiabetics Basic Information Table 75. Merck and Co. Inc. Antidiabetics Product Overview Table 76. Merck and Co. Inc. Antidiabetics Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 77. Merck and Co. Inc. Business Overview Table 78. Merck and Co. Inc. Recent Developments Table 79. Novo Nordisk Antidiabetics Basic Information Table 80. Novo Nordisk Antidiabetics Product Overview Table 81. Novo Nordisk Antidiabetics Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 82. Novo Nordisk Business Overview Table 83. Novo Nordisk Recent Developments Table 84. Bristol-Myers Squibb Antidiabetics Basic Information Table 85. Bristol-Myers Squibb Antidiabetics Product Overview Table 86. Bristol-Myers Squibb Antidiabetics Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 87. Bristol-Myers Squibb Business Overview Table 88. Bristol-Myers Squibb Recent Developments Table 89. Halozyme Therapeutics Antidiabetics Basic Information Table 90. Halozyme Therapeutics Antidiabetics Product Overview Table 91. Halozyme Therapeutics Antidiabetics Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 92. Halozyme Therapeutics Business Overview Table 93. Halozyme Therapeutics Recent Developments Table 94. Pfizer Antidiabetics Basic Information Table 95. Pfizer Antidiabetics Product Overview Table 96. Pfizer Antidiabetics Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 97. Pfizer Business Overview Table 98. Pfizer Recent Developments Table 99. Global Antidiabetics Sales Forecast by Region (K Units) Table 100. Global Antidiabetics Market Size Forecast by Region (M USD) Table 101. North America Antidiabetics Sales Forecast by Country (2022-2028) & (K Units) Table 102. North America Antidiabetics Market Size Forecast by Country (2022-2028) & (M USD) Table 103. Europe Antidiabetics Sales Forecast by Country (2022-2028) & (K Units) Table 104. Europe Antidiabetics Market Size Forecast by Country (2022-2028) & (M USD) Table 105. Asia Pacific Antidiabetics Sales Forecast by Region (2022-2028) & (K Units) Table 106. Asia Pacific Antidiabetics Market Size Forecast by Region (2022-2028) & (M USD) Table 107. South America Antidiabetics Sales Forecast by Country (2022-2028) & (K Units) Table 108. South America Antidiabetics Market Size Forecast by Country (2022-2028) & (M USD) Table 109. Middle East and Africa Antidiabetics Consumption Forecast by Country (2022-2028) & (Units) Table 110. Middle East and Africa Antidiabetics Market Size Forecast by Country (2022-2028) & (M USD) Table 111. Global Antidiabetics Sales Forecast by Type (2022-2028) & (K Units) Table 112. Global Antidiabetics Market Size Forecast by Type (2022-2028) & (M USD) Table 113. Global Antidiabetics Price Forecast by Type (2022-2028) & (USD/Unit) Table 114. Global Antidiabetics Sales (K Units) Forecast by Application (2022-2028) Table 115. Global Antidiabetics Market Size Forecast by Application (2022-2028) & (M USD) LIST OF FIGURES Figure 1. Product Picture of Antidiabetics Figure 2. Data Triangulation Figure 3. Key Caveats Figure 4. Global Antidiabetics Market Size (M USD), 2017-2028 Figure 5. Global Antidiabetics Market Size (M USD) (2017-2028) Figure 6. Global Antidiabetics Sales (K Units) & (2017-2028) Figure 7. Evaluation Matrix of Segment Market Development Potential (Type) Figure 8. Evaluation Matrix of Segment Market Development Potential (Application) Figure 9. Evaluation Matrix of Regional Market Development Potential Figure 10. Antidiabetics Market Size (M USD) by Country (M USD) Figure 11. Antidiabetics Sales Share by Manufacturers in 2020 Figure 12. Global Antidiabetics Revenue Share by Manufacturers in 2020 Figure 13. Antidiabetics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 14. Global Market Antidiabetics Average Price (USD/Unit) of Key Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Players: Market Share by Antidiabetics Revenue in 2021 Figure 16. Evaluation Matrix of Segment Market Development Potential (Type) Figure 17. Global Antidiabetics Market Share by Type Figure 18. Sales Market Share of Antidiabetics by Type (2017-2022) Figure 19. Sales Market Share of Antidiabetics by Type in 2021 Figure 20. Market Size Share of Antidiabetics by Type (2017-2022) Figure 21. Market Size Market Share of Antidiabetics by Type in 2020 Figure 22. Evaluation Matrix of Segment Market Development Potential (Application) Figure 23. Global Antidiabetics Market Share by Application Figure 24. Global Antidiabetics Sales Market Share by Application (2017-2022) Figure 25. Global Antidiabetics Sales Market Share by Application in 2021 Figure 26. Global Antidiabetics Market Share by Application (2017-2022) Figure 27. Global Antidiabetics Market Share by Application in 2020 Figure 28. Global Antidiabetics Sales Growth Rate by Application (2017-2022) Figure 29. Global Antidiabetics Sales Market Share by Region (2017-2022) Figure 30. North America Antidiabetics Sales and Growth Rate (2017-2022) & (K Units) Figure 31. North America Antidiabetics Sales Market Share by Country in 2020 Figure 32. U.S. Antidiabetics Sales and Growth Rate (2017-2022) & (K Units) Figure 33. Canada Antidiabetics Sales (K Units) and Growth Rate (2017-2022) Figure 34. Mexico Antidiabetics Sales (Units) and Growth Rate (2017-2022) Figure 35. Europe Antidiabetics Sales and Growth Rate (2017-2022) & (K Units) Figure 36. Europe Antidiabetics Sales Market Share by Country in 2020 Figure 37. Germany Antidiabetics Sales and Growth Rate (2017-2022) & (K Units) Figure 38. France Antidiabetics Sales and Growth Rate (2017-2022) & (K Units) Figure 39. U.K. Antidiabetics Sales and Growth Rate (2017-2022) & (K Units) Figure 40. Italy Antidiabetics Sales and Growth Rate (2017-2022) & (K Units) Figure 41. Russia Antidiabetics Sales and Growth Rate (2017-2022) & (K Units) Figure 42. Asia Pacific Antidiabetics Sales and Growth Rate (K Units) Figure 43. Asia Pacific Antidiabetics Sales Market Share by Region in 2020 Figure 44. China Antidiabetics Sales and Growth Rate (2017-2022) & (K Units) Figure 45. Japan Antidiabetics Sales and Growth Rate (2017-2022) & (K Units) Figure 46. South Korea Antidiabetics Sales and Growth Rate (2017-2022) & (K Units) Figure 47. India Antidiabetics Sales and Growth Rate (2017-2022) & (K Units) Figure 48. Southeast Asia Antidiabetics Sales and Growth Rate (2017-2022) & (K Units) Figure 49. South America Antidiabetics Sales and Growth Rate (K Units) Figure 50. South America Antidiabetics Sales Market Share by Country in 2020 Figure 51. Brazil Antidiabetics Sales and Growth Rate (2017-2022) & (K Units) Figure 52. Argentina Antidiabetics Sales and Growth Rate (2017-2022) & (K Units) Figure 53. Columbia Antidiabetics Sales and Growth Rate (2017-2022) & (K Units) Figure 54. Middle East and Africa Antidiabetics Sales and Growth Rate (K Units) Figure 55. Middle East and Africa Antidiabetics Sales Market Share by Region in 2020 Figure 56. Saudi Arabia Antidiabetics Sales and Growth Rate (2017-2022) & (K Units) Figure 57. UAE Antidiabetics Sales and Growth Rate (2017-2022) & (K Units) Figure 58. Egypt Antidiabetics Sales and Growth Rate (2017-2022) & (K Units) Figure 59. Nigeria Antidiabetics Sales and Growth Rate (2017-2022) & (K Units) Figure 60. South Africa Antidiabetics Sales and Growth Rate (2017-2022) & (K Units) Figure 61. Global Antidiabetics Sales Forecast by Volume (2017-2028) & (K Units) Figure 62. Global Antidiabetics Market Size Forecast by Value (2017-2028) & (M USD) Figure 63. Global Antidiabetics Sales Market Share Forecast by Type (2022-2028) Figure 64. Global Antidiabetics Market Share Forecast by Type (2022-2028) Figure 65. Global Antidiabetics Sales Forecast by Application (2022-2028) Figure 66. Global Antidiabetics Market Share Forecast by Application (2022-2028)

•Sanofi-Aventis •Takeda Pharmaceuticals •Eli Lilly •Oramed Pharmaceuticals •Boehringer Ingelheim •Merck and Co. Inc. •Novo Nordisk •Bristol-Myers Squibb •Halozyme Therapeutics •Pfizer